Name | 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]-1-benzofuran-6-sulfonamide |
---|---|
Synonyms |
3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]-1-benzofuran-6-sulfonamide
1t4j 6-Benzofuransulfonamide, 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-[(2-thiazolylamino)sulfonyl]phenyl]- PTP1B Inhibitor FRJ |
Description | PTP1B-IN-4 is a non-competitive allosteric inhibitor of the protein tyrosine phosphatase PTP1B, with an IC50 of 8 μM. PTP1B-IN-4 is potentail for the research of obesity and diabetes[1][2]. |
---|---|
Related Catalog | |
Target |
IC50: 8 μM (PTP1B)[1] |
In Vitro | PTP1B-IN-4 (250 µM; 1 hour) stimulates insulin receptor (IR) phosphorylation in CHO cells overexpressing human IR[1]. PTP1B-IN-4 also induces phosphorylation of IRS-1 and Akt, proteins downstream of the insulin receptor[1]. Western Blot Analysis[1] Cell Line: CHO cells Concentration: 250 µM Incubation Time: 1 hour Result: Stimulated insulin receptor phosphorylation. |
References |
Density | 1.8±0.1 g/cm3 |
---|---|
Boiling Point | 855.0±75.0 °C at 760 mmHg |
Molecular Formula | C26H19Br2N3O7S3 |
Molecular Weight | 741.448 |
Flash Point | 470.9±37.1 °C |
Exact Mass | 738.875183 |
PSA | 200.67000 |
LogP | 6.80 |
Vapour Pressure | 0.0±3.3 mmHg at 25°C |
Index of Refraction | 1.727 |